Parallax Volatility Advisers, L.P. Crispr Therapeutics Ag Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $1.48 Million - $1.93 Million	32,646 New	32,646 $1.48 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $961,122 - $1.32 Million	23,442 New	23,442 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $441,325 - $605,142	7,223 New	7,223 $472,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $1.48 Million - $2.21 Million	-27,892 Reduced 52.29%	25,445 $1.6 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $1.94 Million - $3.09 Million	-27,730 Reduced 34.21%	53,337 $4.04 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $8.91 Million - $12.7 Million	80,827 Added 33677.92%	81,067 $9.07 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $2.86 Million - $4.59 Million	-28,331 Reduced 99.16%	240 $39,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $3.16 Million - $6 Million	28,571 New	28,571 $3.48 Million

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.